Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Wide Dissemination of a Carbapenemase Plasmid among Gram-Negative Bacteria: Implications of the Variable Phenotype

Björn Espedido, Jonathan Iredell, Lee Thomas, Anna Zelynski
Björn Espedido
Centre for Infectious Diseases and Microbiology Westmead Hospital, University of Sydney Sydney, New South Wales, Australia 2145
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Iredell
Centre for Infectious Diseases and Microbiology Westmead Hospital, University of Sydney Sydney, New South Wales, Australia 2145
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joni@icpmr.wsahs.nsw.gov.au
Lee Thomas
Centre for Infectious Diseases and Microbiology Westmead Hospital, University of Sydney Sydney, New South Wales, Australia 2145
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Zelynski
Centre for Infectious Diseases and Microbiology Westmead Hospital, University of Sydney Sydney, New South Wales, Australia 2145
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.43.9.4918-4919.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Broad-spectrum carbapenem antibiotics are the last bastion of empirical therapy for resistant gram-negative bacterial infections, and outbreaks of carbapenem-resistant bacterial infection may be associated with greatly increased mortality in the critically ill (4). Carbapenems (e.g., imipenem, meropenem, ertapenem) are increasingly threatened by dissemination of metallo-β-lactamases (MβLs), the most important of which are the integron-borne members of the VIM and IMP families. Integrons are genetic elements able to capture and express antibiotic resistance determinants in the form of gene cassettes via site-specific recombination (7). Class 1 integrons are dominant among the four classes associated with antibiotic resistance, and plasmids are important vectors for their transmission between bacteria in the hospital environment. While transmissible MβLs are increasingly reported throughout Asia, Europe, and South America, Australia has only recently observed the emergence of an MβL, IMP-4 (5). We found the blaIMP-4 gene cassette as the first of four in a class 1 integron-associated array (GenBank accession no. AJ609296 ), which also includes an aacA4 gene cassette conferring resistance to gentamicin and tobramycin. This array was present on a large conjugative plasmid (pJIBE401) in a clinical isolate of Klebsiella pneumoniae (Kp1239) referred to our laboratory (2).

With the arrival of a new gene or set of genes in the gram-negative microflora, it is necessary to determine both its transmissibility characteristics and the resulting phenotype to understand the threat it poses. This means assessing the efficiency of transmission and the host range of the transmissible trait, as well as defining the relevant antibiotic resistance phenotype and any potential disadvantage to the organism in terms of growth characteristics or biological fitness (that is, the chance of being segregated out of the microflora by failing to compete in the absence of selection pressure). We therefore mated Kp1239 with rifampin-resistant recipient strains generated from a range of wild-type enteric bacteria, performing conjugation experiments as previously described (1). Transmission of blaIMP-4-bearing plasmid pJIBE401 from Kp1239 into Escherichia coli (EcUB5201Rf) and Enterobacter aerogenes (Ea13048Rf) occurred at a frequency of 10−2, while transmission into Citrobacter freundii (Cf4000Rf) and K. pneumoniae (Kp13883Rf) occurred at frequencies of 10−6 and 10−7, respectively. Serratia marcescens (Sm1002Rf) transconjugants were also generated, at frequencies of ≤10−9 (Table 1). Attempts to introduce pJIBE401 from Kp1239 into Acinetobacter baumannii and Pseudomonas aeruginosa were repeatedly unsuccessful.

Since the detection of Kp1239, we have observed blaIMP-4 in a number of other enteric bacteria isolated from patients within our region. The clinical isolates K. pneumoniae Kp1239 and Kp2730, Enterobacter cloacae El3518, and Citrobacter amalonaticus Ca3927 are all temporally and geographically distinct and readily separated by DNA fingerprinting (enterobacterial repeat intergenic consensus sequence typing; data not shown) (6). These isolates were used for conjugation experiments into EcUB5201Rf (Table 2). All appeared to have a common high-molecular-weight plasmid of the same size as pJIBE401 (>150 kb; data not shown) carrying identical gene cassettes, consistent with that plasmid's widespread dissemination.

MICs were determined by Vitek 2 AST-N019 gram-negative susceptibility card (Vitek AMS; BioMérieux Vitek Systems Inc., Hazelwood, Mo.), except for imipenem, which was determined by Etest (AB BIODISK, Solna, Sweden). Most blaIMP-4-bearing transconjugants expressed resistance below the Clinical and Laboratory Standards Institute clinical breakpoint for imipenem sensitivity (Table 1), and we therefore tested whether we could induce higher-level resistance in these strains upon antibiotic exposure in vitro. Kp2730, an imipenem-intermediate (MIC, 8 μg ml−1) clinical isolate, was compared with Kp13883Rf/pJIBE401 transconjugants, which were imipenem sensitive (MIC, 3 μg ml−1; Table 1). Kp2730 (but not Kp13883Rf/pJIBE401) grew as isolated colonies on nutrient agar (Difco) containing 16 μg ml−1 of imipenem, occurring at a frequency of 10−1 to 10−2. A loopful of these colonies was amplified in nutrient broth (Difco) with 16 μg ml−1 of imipenem and further subcultured on 64 μg ml−1 of imipenem in nutrient agar with a 10−1 to 10−2 yield of isolated colonies again (compared with growth on nonselective medium). A loopful of the highly resistant Kp2730-derived mutants (Kp2730R, obtained from the plates containing 64 μg ml−1 of imipenem) was resuspended in nutrient broth, and 100 CFU each of these and of Kp1239, Kp2730, Kp13883Rf, and KP13883Rf/pJIBE401, at log phase, was used to inoculate separate aerobic Bactec 9000 blood culture bottles (BD Diagnostics). All bottles signaled as positive after overnight incubation, with no significant difference in growth rates (Kp1239 and Kp2730 bottles signaled positive at 10 h; Kp13883Rf, KP13883Rf/pJIBE401, and Kp2730R at 11 h), and the high imipenem MICs (≥64 μg ml−1) persisted on subculture.

Decreased outer membrane permeability is one logical explanation for the high carbapenem MICs for some Klebsiella and Enterobacter strains (Tables 1 and 2), but the Kp2730R mutants have not yet been examined in detail. The integron promoter remained unchanged in Kp2730R, and EcUB5201Rf transconjugants displayed little difference in carbapenem MICs as determined by Etests (data not shown), indicating the lack of plasmid involvement in the increased resistance seen. However, ompK36 encodes a porin of known relevance to carbapenem resistance in Klebsiella (3) and we have found this to be disrupted by an insertion sequence in Kp1239 (our unpublished data). Thus, we conclude that a broad-host-range plasmid carrying blaIMP-4 and aacA4 is efficiently transmitted to a wide variety of gram-negative bacteria, that efficiency presumably varying both within and between species, resulting in an elevated MIC of carbapenems which is often still in the sensitive range, but from which stable high-level resistance can be readily selected, at least in some K. pneumoniae strains. This occurs without an obvious growth defect in optimal media and is likely to be clinically important.

The efficient horizontal transfer of resistance genes between gram-negative bacteria in the face of intensive selection pressure in hospitals poses a great problem. The conditional nature of resistance phenotypes such as we describe further complicates infection control measures. Detection of these independent bacterial isolates over the past year suggests dissemination throughout our microflora of a newly arrived panresistance to the main β-lactams and aminoglycosides. This is a reminder that we need to manage gram-negative resistance surveillance thoughtfully and that we need to think of outbreaks in terms of the transmitted unit (typically a plasmid) and the vagaries of its host range and phenotype.

(These data were presented in part at the Annual Scientific Meeting of the Australian Society for Microbiology, Sydney, Australia, 2004.)

View this table:
  • View inline
  • View popup
TABLE 1.

MICs of various drugs for the isolates studied

View this table:
  • View inline
  • View popup
TABLE 2.

MICs of various drugs for clinical isolates and transconjugants

ACKNOWLEDGMENTS

None of the authors have a commercial interest or any other association that might pose a conflict of interest.

B.E. is supported by an Australian Postgraduate Award.

  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Dehio, C., and M. Meyer. 1997. Maintenance of broad-host-range incompatibility group P and group Q plasmids and transposition of Tn5 in Bartonella henselae following conjugal plasmid transfer from Escherichia coli. J. Bacteriol.179:538-540.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Espedido, B., and J. R. Iredell. Submitted for publication.
  3. 3.↵
    Hernandez-Alles, S., V. J. Benedi, L. Martinez-Martinez, A. Pascual, A. Aguilar, J. M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother.43:937-939.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Playford, E. G., J. C. Craig, J. Simpson, and J. R. Iredell. 2003. Abstracts of the 43rd Interscience Conference on Antimicrobial Agents Chemotherapy, abstr. K711. American Society for Microbiology, Washington, D.C.
  5. 5.↵
    Poirel, L., J. N. Pham, L. Cabanne, B. J. Gatus, S. M. Bell, and P. Nordmann. 2004. Carbapenem-hydrolysing metallo-β-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia. Pathology36:366-367.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Rodriguez-Barradas, M., R. Hamill, E. Houston, P. Georghiou, J. Clarridge, R. Regnery, and J. Koehler. 1995. Genomic fingerprinting of Bartonella species by repetitive element PCR for distinguishing species and isolates. J. Clin. Microbiol.33:1089-1093.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Stokes, H. W., and R. M. Hall. 1989. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol.3:1669-1683.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Wide Dissemination of a Carbapenemase Plasmid among Gram-Negative Bacteria: Implications of the Variable Phenotype
Björn Espedido, Jonathan Iredell, Lee Thomas, Anna Zelynski
Journal of Clinical Microbiology Sep 2005, 43 (9) 4918-4919; DOI: 10.1128/JCM.43.9.4918-4919.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Wide Dissemination of a Carbapenemase Plasmid among Gram-Negative Bacteria: Implications of the Variable Phenotype
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Wide Dissemination of a Carbapenemase Plasmid among Gram-Negative Bacteria: Implications of the Variable Phenotype
Björn Espedido, Jonathan Iredell, Lee Thomas, Anna Zelynski
Journal of Clinical Microbiology Sep 2005, 43 (9) 4918-4919; DOI: 10.1128/JCM.43.9.4918-4919.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Proteins
Conjugation, Genetic
Drug Resistance, Bacterial
Gene Transfer, Horizontal
Gram-negative bacteria
plasmids
beta-lactamases

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X